CUSIP: 12648L106
Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
41,187,151
-
Share change
-
+41,148,105
-
Total reported value
-
$115,732,038
-
Put/Call ratio
-
28%
-
Price per share
-
$2.81
-
Number of holders
-
82
-
Value change
-
+$115,622,036
-
Number of buys
-
80
Quarterly Holders Quick Answers
What is CUSIP 12648L106?
CUSIP 12648L106 identifies CTIC - CTI BIOPHARMA CORP - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 12648L106:
Institutional Holders of CTI BIOPHARMA CORP - COM (CTIC) as of Q2 2014
As of 30 Jun 2014,
CTI BIOPHARMA CORP - COM (CTIC) was held by
82 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
41,187,151 shares.
The largest 10 holders included
EAGLE ASSET MANAGEMENT INC, State Street Corp, BlackRock Institutional Trust Company, N.A., VANGUARD GROUP INC, FMR LLC, BlackRock Fund Advisors, NORTHERN TRUST CORP, JANE STREET GROUP, LLC, TEACHERS ADVISORS INC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
82
institutional shareholders reporting positions in this security
for the Q2 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.